Alibaba Health Information Technology Ltd Financials

Market Capitalization HK$53.59 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	41.63
Forward PE	19.59
Price to Sales TTM	HK$1.89
Price to Book MRQ	HK$3.50
Enterprise to Revenue	1.70
Enterprise to EBITDA	47.11

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-03-31
Profit Margin	4.26%
Operating Margin	3.62%
Return on Assets TTM	2.99%
Return on Equity TTM	7.71%

Income Statement

Revenue TTM	HK$30,420,270,725
Revenue per Share TTM	HK$1.85
Quarterly Revenue Growth	10.20%
Gross Profit TTM	HK$7,040,915,911
EBITDA	HK$926,083,000
Net Income to Common TTM	HK$1,294,908,338
Diluted EPS TTM	HK$0.08
Quarterly Earnings Growth YoY	72.50%

Balance Sheet

Total Cash MRQ	HK$8,300,111,426
Total Cash per Share MRQ	HK$0.48
Total Debt MRQ	HK$
Total Debt to Equity MRQ	0.45
Current Ratio MRQ	2.45
Book Value per Share MRQ	HK$0.95

Cash Flow

Operating Cash Flow TTM	HK$785,414,568
Levered Free Cash Flow TTM	HK$-15,679,126

0241 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	16,091,799,552
Float Shares	5,796,203,970
Avg 10 Volume	36,051,009
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	63.85%
% Held by Institutions	12.28%

Stock Price Summary

Beta
Fifty Two Week Low	HK$2.59
Fifty Two Week High	HK$6.30
Fifty Two Week Change	8.48%
Day 50 MA	HK$3.54
Day 200 MA	HK$3.42

Dividends and Splits

Forward Annual Dividend Rate	HK$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	HK$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date